Prohibition on expenditure of Medicaid funds for cross-sex hormones for treatment of gender dysphoria or gender reassignment surgery
KRS 205.5365
in effect205.5365. Prohibition on expenditure of Medicaid funds for cross-sex hormones for treatment of gender dysphoria or gender reassignment surgery
Notwithstanding any provision of law to the contrary and unless required under federal law, the Department for Medicaid Services and any managed care organization with whom the department contracts for the delivery of Medicaid services are hereby prohibited from expending any Medicaid funds on any of the following:
(1) Cross-sex hormones when prescribed or administered primarily or solely for the treatment of gender dysphoria; and
(2) Gender reassignment surgery to alter or remove physical or anatomical characteristics or features that are typical for and characteristic of a person's biological sex.
Effective: June 27, 2025
History: Created 2025 Ky. Acts ch. 107, sec. 1, effective June 27, 2025; and ch. 161, sec. 2, effective June 27, 2025.
Legislative Research Commission Note (6/27/2025). This statute was created by 2025 RS HB 495 (2025 Ky. Acts ch. 107, sec. 1) and subsequently amended by 2025 RS HB 501 (2025 Ky. Acts ch. 161, sec. 2), and the amendment has been incorporated in codification.
Source: Kentucky Legislative Research Commission (legislature.ky.gov)URL: https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=56368Fetched: 10/20/2026
